Halhouli, T.; Münchhalfen, L.; Hamad, S.; Schmitz-Ullrich, L.; Nitsche, F.; Gaedke, F.; Schauss, A.; Zhang, L.; Pham, Q.-K.; Bao, G.;
et al. Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting. Bioengineering 2025, 12, 657.
https://doi.org/10.3390/bioengineering12060657
AMA Style
Halhouli T, Münchhalfen L, Hamad S, Schmitz-Ullrich L, Nitsche F, Gaedke F, Schauss A, Zhang L, Pham Q-K, Bao G,
et al. Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting. Bioengineering. 2025; 12(6):657.
https://doi.org/10.3390/bioengineering12060657
Chicago/Turabian Style
Halhouli, Tasneem, Lisa Münchhalfen, Sarkawt Hamad, Larissa Schmitz-Ullrich, Frank Nitsche, Felix Gaedke, Astrid Schauss, Linlin Zhang, Quoc-Khanh Pham, Gang Bao,
and et al. 2025. "Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting" Bioengineering 12, no. 6: 657.
https://doi.org/10.3390/bioengineering12060657
APA Style
Halhouli, T., Münchhalfen, L., Hamad, S., Schmitz-Ullrich, L., Nitsche, F., Gaedke, F., Schauss, A., Zhang, L., Pham, Q.-K., Bao, G., & Pfannkuche, K. P.
(2025). Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting. Bioengineering, 12(6), 657.
https://doi.org/10.3390/bioengineering12060657